References
- Cuilleret F. J., Agraou B., Kyndt X., Cuilleret V., Agraou H., el Mansour N., et al. Cardiac effects of dermatomyositis. A case report. Arch Mal Coeur Vaiss 2003; 96: 919–22
- Gonzalez‐Lopez L., Gamez‐Nava J. I., Sanchez L., Rosas E., Suarez‐Almazor M., Cardona‐Munoz C., et al. Cardiac manifestations in dermato‐polymyositis. Clin Exp Rheumatol 1996; 14: 373–9
- Marschalko M., Ponyai G., Ablonczy E., Horvath A. Dermatomyositis: clinical study of 34 patients. Orv Hetil 2000; 141: 225–9
- Ramanan A. V., Feldman B. M. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002; 28: 833–57
- Schwarz M. I. Pulmonary and cardiac manifestations of polymyositis–dermatomyositis. J Thorac Imaging 1992; 7: 46–54
- Shehata R., al‐Mayouf S., al‐Dalaan A., al‐Mazaid A., al‐Balaa S., Bahabri S. Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol 1999; 17: 115–18
- Tami L. F., Bhasin S. Polymorphism of the cardiac manifestations in dermatomyositis. Clin Cardiol 1993; 16: 260–4
- Terada Y., Mitsui T., Yamamoto T. Enlargement of the right atrium associated with dermatomyositis. Ann Thorac Surg 1995; 59: 263–4
- Hicks J. E., Drinkard B., Summers R. M., Rider L. G. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002; 47: 118–23
- Dalakas M. C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971–82
- Mok C. C., To C. H., Szeto M. L. Successful treatment of dermatomyositis‐related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. Scand J Rheumatol 2003; 32: 181–3
- Riemekasten G., Opitz C., Audring H., Barthelmes H., Meyer R., Hiepe F., et al. Beware of the heart: the multiple picture of cardiac involvement in myositis. Rheumatology (Oxford) 1999; 38: 1153–7
- Imakita M., Yutani C., Ishibashi‐Ueda H., Miyatake K. A case of overlap syndrome of systemic sclerosis and dermatomyositis with right ventricular dysplasia. Hum Pathol 1991; 22: 504–6
- Pardo J., Meruane J., Staeding J., Drago G., Etchart M. Cardiac involvement in polymyositis–dermatomyositis associated with Sjogren's syndrome. Rev Med Chil 1995; 122: 550–5
- Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841–2
- Corssmit E. P., Trip M. D., Durrer J. D. Löffler's endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology 1999; 91: 272–6
- Mossner R., Tings T Beckmann I., Neumann C., Paulus W Reich K. A close look at autoimmune muscle disorders: association of Lambert–Eaton myasthenic syndrome with dermatomyositis. Scand J Rheumatol 2004; 33: 271–6
- Pickering M. C., Walport M. J. Eosinophilic myopathic syndromes. Curr Opin Rheumatol 1998; 10: 504–10
- Ammash N. M., Seward J. B., Bailey K. R., Edwards W. D., Tajik A. J. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 2000; 101: 2490–6
- Kupferstein R., Feinberg M. S., Rosenblat S., Beker B., Eldar M., Schwammenthal E. Prevalence, etiology, and outcome of patients with restrictive left ventricular filling and relatively preserved systolic function. Am J Cardiol 2003; 91: 1517–19